Tate & Lyle to launch innovative new starch
CREAMIZ will reduce fat content by up to 30% while bringing creaminess and texture Manufacturers set to benefit from reduced cost base
Tate Lyle has today announced the European launch of an innovative new starch for use in dairy and convenience foods. The starch, named CREAMIZ, will help manufacturers reduce fat content by up to 30%, while maintaining mouthfeel and texture.
CREAMIZ has been introduced as a part of Tate Lyle’s Optimize™ platform and will help deliver significant cost savings for food manufacturers. Tate Lyle’s Optimize™ platform helps our customers cut their costs and optimise their processes.
CREAMIZ uses unique starch modification technology to make it a leading contender for fat substitution in a wide range for food products. It will not affect the creaminess of products it is used in, but instead will complement and enhance their existing texture creating a rich and full bodied flavour.
Tate Lyle has already developed several prototypes using CREAMIZ, including low-fat cream desserts and yogurts, and is now working with its customers to optimise and create additional recipes. A range of prototypes will be on display at the Tate Lyle stand Number 8M35 at Food Ingredients Europe 09.
Commenting, Clotilde Feuillade, Product Manager for Texturants at Tate Lyle Food Ingredients Europe said, “With the continuing move towards health and wellness consumers are placing more emphasis than ever before on a balanced diet. CREAMIZ will help manufacturers respond to this, by reducing the fat content of their products while keeping the cost down.
“CREAMIZ is special in that it will do so without having any negative effect on taste. Feedback from our customers has shown that consumers really value the creamy mouthfeel of traditional dairy products, now they’ll be able to experience it in low-fat foods.
“Because modified food starches are used in a wide range of food products, CREAMIZ can, in many cases, be used to reduce the fat content without adding an additional ingredient to the ingredient declaration on the label. Moreover, in addition to its functional and nutritional benefits CREAMIZ can be used on standard food manufacturing lines and does not require specific equipment to be added. Given that it will help reduce costs and improve the nutritional profile of customers’ products we expect it to be extremely popular.”
Caroline Sanders, Marketing Director at Tate Lyle Food Ingredients Europe added, “We are committed to expanding our portfolio of products produced in Europe and continue to work on a range of new food starches and applications.”
Tate Lyle operates through two global business units, Speciality Food Ingredients and Bulk Ingredients, supported by Innovation and Commercial Development. The Group's strategy is to become the leading global provider of Speciality Food Ingredients through a disciplined focus on growth, and by driving the Bulk Ingredients business for sustained cash generation to fuel this growth.
Speciality Food Ingredients include starch-based speciality ingredients (corn-based speciality starches, sweeteners and fibres), no calorie sweeteners (including SPLENDA® Sucralose) and Food Systems which provides blended ingredient solutions. Bulk Ingredients include corn-based bulk sweeteners, industrial starches and fermentation products (primarily acidulants). The co-products from both divisions are primarily sold as animal feed.
Tate Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2012, Tate Lyle sales totalled £3.1 billion. http://www.tateandlyle.com. SPLENDA® is a trademark of McNeil Nutritionals, LLC
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
